Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
28-29
pubmed:dateCreated
1998-8-18
pubmed:abstractText
Thrombolysis using tissue plasminogen activator (tPA) is not the leading strategy in the development of pharmacological treatments for acute ischaemic stroke. The prospect of tPA becoming routine treatment in ischaemic stroke raises several issues the magnitude of the treatment load, the requisite neurological and neuroradiological diagnostic qualifications, identification of local reperfusion effects in the brain, and the pre-hospital and hospital management of acute stroke patients. The results of large randomised trials of intravenous tPA treatment are reviewed in the article, and the current state of our knowledge about interventional thrombolysis is reported. Recruitment for the second European intravenous tPA trail, ECASS II, has recently been completed, and the study findings will be available during the latter half of 1988. In the USA, tPA is already recommended treatment for acute ischaemic stroke within three hours after the onset of symptoms. In Europe, the formulation of guidelines awaits the results of ECASS II.
pubmed:language
swe
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0023-7205
pubmed:author
pubmed:issnType
Print
pubmed:day
8
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3202-11
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9700267-Cerebral Infarction, pubmed-meshheading:9700267-Cerebrovascular Disorders, pubmed-meshheading:9700267-Continuity of Patient Care, pubmed-meshheading:9700267-Diagnosis, Differential, pubmed-meshheading:9700267-Emergencies, pubmed-meshheading:9700267-Humans, pubmed-meshheading:9700267-Injections, Intra-Arterial, pubmed-meshheading:9700267-Injections, Intravenous, pubmed-meshheading:9700267-Intracranial Embolism and Thrombosis, pubmed-meshheading:9700267-Patient Care Planning, pubmed-meshheading:9700267-Prognosis, pubmed-meshheading:9700267-Randomized Controlled Trials as Topic, pubmed-meshheading:9700267-Reperfusion, pubmed-meshheading:9700267-Thrombolytic Therapy, pubmed-meshheading:9700267-Tissue Plasminogen Activator, pubmed-meshheading:9700267-Tomography, X-Ray Computed
pubmed:year
1998
pubmed:articleTitle
[Thrombolysis changes the care of stroke].
pubmed:affiliation
Neurologiska kliniken, Karolinska sjukhuset, Stockholm.
pubmed:publicationType
Journal Article, English Abstract, Review